Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Cardiovasc Res. 2004 Oct 1;64(1):61–71. doi: 10.1016/j.cardiores.2004.05.011

Table 1.

Reasons for excluding mice from the study

Infarct studies
Immunohistochemistry
Biochemical analyses
Total
Group I Group II Group III Group IV Group V Groups VI–XX
Death 0 4 0 3 0 2 9
Technical problems 1 2 0 0 0 4 7
Poor postmortem staining 2 1 0 0 0 0 3
Mice excluded 3 7 0 3 0 6 19
Mice instrumented 20 16 9 12 6 88 151
Mice included in study 17 9 9 9 6 82 132
Mice included in study (%) 85 56 100 75 100 93 87